TY - JOUR T1 - The Effects of India’s COVID-19 Lockdown on Critical Non-COVID Health Care and Outcomes JF - medRxiv DO - 10.1101/2020.09.19.20196915 SP - 2020.09.19.20196915 AU - Radhika Jain AU - Pascaline Dupas Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/20/2020.09.19.20196915.abstract N2 - India’s COVID-19 lockdown is widely believed to have disrupted critical health services, but its effect on non-COVID health outcomes is largely unknown. Comparing mortality trends among dialysis patients in the eight months around the lockdown with the previous year, we document a 64% increase in mortality between March and May 2020 and an estimated 22-25% total excess mortality through July 2020. The mortality increase is greater among females and disadvantaged groups. Barriers to transportation and disruptions in hospital services appear to be the main drivers of increased morbidity and mortality. The results highlight the unintended consequences of the lockdown on critical and life-saving non-COVID health services that must be taken into account in the implementation of future policy efforts to control the spread of pandemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by a grant from the Bill and Melinda Gates Foundation, awarded through the J-PAL CaTCH Initiative special COVID-19 funding windowAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Stanford University, USA (protocol no. 41683); Institution for Financial Management and Research, IndiaAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesReplication code and deidentified survey data will be made available at the time of publication on the author websites. ER -